Table 1.
Baseline characteristics of 108 243 individuals in the Copenhagen General Population Study
Centile (mmol/L, mg/dL) | ||||||||
---|---|---|---|---|---|---|---|---|
1st-5th (<1.8, <70) | 6th-20th (1.8-2.3, 70-92) | 21st-40th (2.4-2.8, 93-112) | 41st-60th (2.9-3.3, 113-131) | 61st-80th (3.4-3.9, 132-154) | 81st-95th (4.0-4.8, 155-189) | 96th-100th (>4.8, >189) | All | |
No of individuals | 6412 (6) | 15 681 (14) | 21 289 (20) | 22 207 (21) | 21 892 (20) | 15 999 (15) | 4763 (4) | 108 243 |
Women | 3202 (50) | 9068 (58) | 11 973 (56) | 12 385 (56) | 11 710 (53) | 8537 (53) | 2699 (57) | 59 574 (55) |
Age (years) | 62 (47-72) | 56 (45-68) | 56 (46-67) | 58 (48-67) | 59 (50-67) | 60 (51-67) | 60 (52-67) | 58 (48-67) |
Smoker | 961 (15) | 2441 (16) | 3291 (15) | 3674 (17) | 3872 (18) | 3203 (20) | 1107 (23) | 18 549 (17) |
Pack years, ever smokers | 20 (8-38) | 15 (5-30) | 14 (5-29) | 15 (6-30) | 16 (7-30) | 18 (7-31) | 19 (8-32) | 16 (6-30) |
Systolic blood pressure (mm Hg) | 137 (124-151) | 136 (122-151) | 137 (124-152) | 140 (126-154) | 141 (128-156) | 144 (130-159) | 145 (132-160) | 140 (126-155) |
Lipid lowering treatment | 3030 (47) | 4166 (27) | 2891 (14) | 1584 (7) | 849 (4) | 373 (2) | 132 (3) | 13 025 (12) |
Diabetes | 1249 (19) | 1218 (8) | 822 (4) | 563 (3) | 401 (2) | 269 (2) | 83 (2) | 4605 (4) |
Atherosclerotic cardiovascular disease | 1806 (28) | 2262 (14) | 1756 (8) | 1413 (6) | 1200 (5) | 817 (5) | 223 (5) | 9477 (9) |
Cancer | 557 (9) | 1093 (7) | 1393 (7) | 1474 (7) | 1508 (7) | 1081 (7) | 327 (7) | 7433 (7) |
Chronic obstructive pulmonary disease | 1218 (19) | 2517 (16) | 3224 (15) | 3324 (15) | 3246 (15) | 2331 (15) | 666 (14) | 16 526 (15) |
LDL-C (mmol/L) | 1.6 (1.4-1.7) | 2.2 (2.0-2.3) | 2.7 (2.6-2.8) | 3.2 (3.1-3.3) | 3.7 (3.6-3.9) | 4.4 (4.2-4.6) | 5.3 (5.1-5.7) | 3.2 (2.6-3.8) |
LDL-C (mg/dL) | 62 (54-66) | 85 (77-89) | 104 (101-108) | 124 (119-128) | 143 (139-150) | 170 (162-178) | 205 (197-219) | 124 (101-147) |
Values are median (interquartile range) or number (%).
LDL-C=low density lipoprotein cholesterol.